PTEN Loss Promotes Mitochondrially Dependent Type II Fas-Induced Apoptosis via PEA-15

REFERENCES

• Algeciras-Schimnich, A., E. M. Pietras, B. C. Barnhart, P. Legembre, S. Vijayan, S. L. Holbeck, and M. E. Peter. 2003. Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc. Natl. Acad. Sci. USA 100:11445–11450.
   PubMed Web of Science ®Google Scholar
• Barnhart, B. C., E. C. Alappat, and M. E. Peter. 2003. The CD95 type I/type II model. Semin. Immunol. 15:185–193.
   PubMed Web of Science ®Google Scholar
• Bertram, J., J. W. Peacock, C. Tan, A. L. Mui, S. W. Chung, M. E. Gleave, S. Dedhar, M. E. Cox, and C. J. Ong. 2006. Inhibition of the phosphatidylinositol 3′-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Res. 66:4781–4788.
   PubMedGoogle Scholar
• Bonni, A., A. Brunet, A. E. West, S. R. Datta, M. A. Takasu, and M. E. Greenberg. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358–1362.
   PubMed Web of Science ®Google Scholar
• Breitschopf, K., J. Haendeler, P. Malchow, A. M. Zeiher, and S. Dimmeler. 2000. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol. Cell. Biol. 20:1886–1896.
   PubMed Web of Science ®Google Scholar
• Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441–444.
   PubMed Web of Science ®Google Scholar
• Condorelli, G., G. Vigliotta, A. Cafieri, A. Trencia, P. Andalo, F. Oriente, C. Miele, M. Caruso, P. Formisano, and F. Beguinot. 1999. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18:4409–4415.
   PubMed Web of Science ®Google Scholar
• Curtin, J. F., and T. G. Cotter. 2003. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell. Signal. 15:983–992.
   PubMed Web of Science ®Google Scholar
• Desagher, S., A. Osen-Sand, S. Montessuit, E. Magnenat, F. Vilbois, A. Hochmann, L. Journot, B. Antonsson, and J. C. Martinou. 2001. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 8:601–611.
   PubMed Web of Science ®Google Scholar
• Deveraux, Q. L., N. Roy, H. R. Stennicke, T. Van Arsdale, Q. Zhou, S. M. Srinivasula, E. S. Alnemri, G. S. Salvesen, and J. C. Reed. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:2215–2223.
   PubMed Web of Science ®Google Scholar
• Di Cristofano, A., P. Kotsi, Y. F. Peng, C. Cordon-Cardo, K. B. Elkon, and P. P. Pandolfi. 1999. Impaired Fas response and autoimmunity in Pten+/− mice. Science 285:2122–2125.
   PubMedGoogle Scholar
• Engedal, N., and H. K. Blomhoff. 2003. Combined action of ERK and NF kappa B mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells. J. Biol. Chem. 278:10934–10941.
   PubMedGoogle Scholar
• Estelles, A., C. A. Charlton, and H. M. Blau. 1999. The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev. Biol. 216:16–28.
   PubMed Web of Science ®Google Scholar
• Fujita, E., Y. Kouroku, Y. Miho, T. Tsukahara, S. Ishiura, and T. Momoi. 1998. Wortmannin enhances activation of CPP32 (caspase-3) induced by TNF or anti-Fas. Cell Death Differ. 5:289–297.
   PubMedGoogle Scholar
• Fukumori, T., Y. Takenaka, N. Oka, T. Yoshii, V. Hogan, H. Inohara, H. O. Kanayama, H. R. Kim, and A. Raz. 2004. Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res. 64:3376–3379.
   PubMed Web of Science ®Google Scholar
• Gibson, S., S. Tu, R. Oyer, S. M. Anderson, and G. L. Johnson. 1999. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J. Biol. Chem. 274:17612–17618.
   PubMed Web of Science ®Google Scholar
• Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193:70–81.
   PubMed Web of Science ®Google Scholar
• Hausler, P., G. Papoff, A. Eramo, K. Reif, D. A. Cantrell, and G. Ruberti. 1998. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol. 28:57–69.
   PubMed Web of Science ®Google Scholar
• Holmstrom, T. H., S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson. 1998. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 160:2626–2636.
   PubMed Web of Science ®Google Scholar
• Holmstrom, T. H., I. Schmitz, T. S. Soderstrom, M. Poukkula, V. L. Johnson, S. C. Chow, P. H. Krammer, and J. E. Eriksson. 2000. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19:5418–5428.
   PubMed Web of Science ®Google Scholar
• Jones, R. G., A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W. C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi. 2002. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196:335–348.
   PubMed Web of Science ®Google Scholar
• Kitsberg, D., E. Formstecher, M. Fauquet, M. Kubes, J. Cordier, B. Canton, G. Pan, M. Rolli, J. Glowinski, and H. Chneiweiss. 1999. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 19:8244–8251.
   PubMed Web of Science ®Google Scholar
• Kubes, M., J. Cordier, J. Glowinski, J. A. Girault, and H. Chneiweiss. 1998. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J. Neurochem. 71:1307–1314.
   PubMed Web of Science ®Google Scholar
• Lee, Y. J., Y. K. Song, J. J. Song, R. R. Siervo-Sassi, H. R. Kim, L. Li, D. R. Spitz, A. Lokshin, and J. H. Kim. 2003. Reconstitution of galectin-3 alters glutathione content and potentiates TRAIL-induced cytotoxicity by dephosphorylation of Akt. Exp. Cell Res. 288:21–34.
   PubMedGoogle Scholar
• Lois, C., E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868–872.
   PubMed Web of Science ®Google Scholar
• Parsons, R. 2004. Human cancer, PTEN and the PI-3 kinase pathway. Semin. Cell Dev. Biol. 15:171–176.
   PubMed Web of Science ®Google Scholar
• Peacock, J. W., and F. R. Jirik. 1999. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR. J. Immunol. 162:215–223.
   PubMedGoogle Scholar
• Peter, M. E., and P. H. Krammer. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:26–35.
   PubMed Web of Science ®Google Scholar
• Podsypanina, K., L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher, and R. Parsons. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96:1563–1568.
   PubMed Web of Science ®Google Scholar
• Ramos, J. W. 2005. Cancer research center hotline: PEA-15 phosphoprotein: a potential cancer drug target. Hawaii Med. J. 64:77–80.
   PubMedGoogle Scholar
• Renganathan, H., H. Vaidyanathan, A. Knapinska, and J. W. Ramos. 2005. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J. 390:729–735.
   PubMed Web of Science ®Google Scholar
• Roy, S., and D. W. Nicholson. 2000. Cross-talk in cell death signaling. J. Exp. Med. 192:F21–F25.
   PubMed Web of Science ®Google Scholar
• Sakai, A., C. Thieblemont, A. Wellmann, E. S. Jaffe, and M. Raffeld. 1998. PTEN gene alterations in lymphoid neoplasms. Blood 92:3410–3415.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675–1687.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., P. H. Krammer, and M. E. Peter. 1999. Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Methods 17:287–291.
   PubMedGoogle Scholar
• Staunton, J. E., D. K. Slonim, H. A. Coller, P. Tamayo, M. J. Angelo, J. Park, U. Scherf, J. K. Lee, W. O. Reinhold, J. N. Weinstein, J. P. Mesirov, E. S. Lander, and T. R. Golub. 2001. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA 98:10787–10792.
   PubMed Web of Science ®Google Scholar
• Strasser, A., A. W. Harris, D. C. Huang, P. H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136–6147.
   PubMed Web of Science ®Google Scholar
• Strauss, G., I. Knape, I. Melzner, and K. M. Debatin. 2003. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J. Immunol. 171:1172–1182.
   PubMedGoogle Scholar
• Suhara, T., T. Mano, B. E. Oliveira, and K. Walsh. 2001. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ. Res. 89:13–19.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., M. Hayashida, H. Kawano, K. Sugimoto, T. Nakano, and K. Shiraki. 2000. Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32:796–802.
   PubMed Web of Science ®Google Scholar
• Tan, Y., H. Ruan, M. R. Demeter, and M. J. Comb. 1999. p90(RSK) blocks Bad-mediated cell death via a protein kinase C-dependent pathway. J. Biol. Chem. 274:34859–34867.
   PubMed Web of Science ®Google Scholar
• Tourian, L., Jr., H. Zhao, and C. B. Srikant. 2004. p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. J. Cell Sci. 117:6459–6471.
   PubMed Web of Science ®Google Scholar
• Trencia, A., A. Perfetti, A. Cassese, G. Vigliotta, C. Miele, F. Oriente, S. Santopietro, F. Giacco, G. Condorelli, P. Formisano, and F. Beguinot. 2003. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol. Cell. Biol. 23:4511–4521.
   PubMed Web of Science ®Google Scholar
• Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248.
   PubMed Web of Science ®Google Scholar
• Wu, X., K. Senechal, M. S. Neshat, Y. E. Whang, and C. L. Sawyers. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95:15587–15591.
   PubMed Web of Science ®Google Scholar
• Yang, B. F., C. Xiao, W. H. Roa, P. H. Krammer, and C. Hao. 2003. Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J. Biol. Chem. 278:7043–7050.
   PubMedGoogle Scholar
• Yin, X. M., K. Wang, A. Gross, Y. Zhao, S. Zinkel, B. Klocke, K. A. Roth, and S. J. Korsmeyer. 1999. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400:886–891.
   PubMed Web of Science ®Google Scholar
• Yuan, X. J., and Y. E. Whang. 2002. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 21:319–327.
   PubMed Web of Science ®Google Scholar